Valuation: Repligen Corporation

Market Cap 7.73B 6.77B 6.29B 5.78B 10.89B 746B 11.06B 74.86B 29.28B 365B 29B 28.38B 1,260B P/E 2026 *
126x
P/E 2027 * 76x
Enterprise Value 7.47B 6.55B 6.09B 5.59B 10.53B 722B 10.69B 72.4B 28.32B 353B 28.05B 27.45B 1,219B EV / Sales 2026 *
9.11x
EV / Sales 2027 * 7.73x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+2.26%
1 week-4.78%
Current month+2.68%
1 month+6.11%
3 months+5.57%
6 months-17.58%
Current year-14.51%
1 week 129
Extreme 129
150.9
1 month 124.85
Extreme 124.85
150.9
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap.
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
6/25/26 Sell

Chief Financial Officer

-733 0.0013%
5/14/26 Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+2.26%-4.78%+22.03%-20.10% 7.73B
+0.90%+13.05%-19.17%-12.00% 174B
-0.56%+3.27%-8.71%-7.95% 105B
-0.82%-0.56%+2.70%+56.07% 58.97B
-1.59%-2.05%+36.71%+59.47% 52.24B
-0.44%+1.67%-12.64%-42.17% 42.39B
-4.89%-3.83% - - 33.05B
-4.44%-3.63%-14.99%-45.31% 28.84B
-0.23%+0.21%+70.61%-5.01% 25.38B
-0.56%+0.88%-5.43%-9.27% 20.64B
Average -1.00%+2.21%+7.90%-2.92% 54.83B
Weighted average by Cap. -0.55%+4.89%-2.50%-0.15%

Financials

2026 *2027 *
Net sales 820M 719M 668M 613M 1.15B 79.16B 1.17B 7.94B 3.11B 38.69B 3.08B 3.01B 134B 944M 828M 769M 706M 1.33B 91.16B 1.35B 9.15B 3.58B 44.55B 3.54B 3.47B 154B
Net income 60.99M 53.46M 49.68M 45.62M 85.91M 5.89B 87.27M 591M 231M 2.88B 229M 224M 9.95B 101M 88.64M 82.36M 75.64M 142M 9.76B 145M 980M 383M 4.77B 380M 371M 16.49B
Net Debt -255M -223M -207M -190M -359M -24.57B -364M -2.47B -965M -12.01B -955M -935M -41.51B -432M -378M -352M -323M -608M -41.67B -618M -4.18B -1.64B -20.37B -1.62B -1.59B -70.39B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-07-22 US$140.09 +2.26% 2,685,526
26-07-21 US$136.99 -5.84% 2,144,924
26-07-20 US$145.49 -1.20% 887,485
26-07-17 US$147.25 -0.88% 912,389
26-07-16 US$148.55 +0.33% 834,858
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
140.09USD
Average target price
178.05USD
Spread / Average Target
+27.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock